Peg-interferon alpha induces CD56bright natural killer cell mediated reduction of HBsAg in entecavir treated chronic Hepatitis B patients

被引：0
|
作者：
Shi, Aichao [1 ]
Zhang, Xiaoping [1 ]
Xiao, Fang [1 ]
Yan, Weiming [1 ]
Han, Meifang [1 ]
Chen, Tao [1 ]
Ning, Qin [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
912
引用
收藏
页码：487A / 487A
页数：1
相关论文
共 50 条
  • [21] Quasispecies analysis of HBV strains isolated from chronic hepatitis B patients treated with Peg-interferon plus Tenofovir therapy
    Lada, Olivier
    Zhang, Qian
    Lapalus, Martine
    Cluzeaud, Francoise
    Martinot-Peignoux, Michelle
    Laouenan, Cedric
    Estrabaud, Emilie
    Boyer, Nathalie
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2012, 56 : 429A - 430A
  • [22] QUASISPECIES ANALYSIS OF HBV STRAINS ISOLATED FROM CHRONIC HEPATITIS B PATIENTS TREATED WITH PEG-INTERFERON plus TENOFOVIR THERAPY
    Lada, O.
    Zhang, Q.
    Lapalus, M.
    Laeounan, C.
    Martinot-Peignoux, M.
    Estrabaud, E.
    Boyer, N.
    Asselah, T.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S306 - S306
  • [23] Quasispecies analysis of HBV strains isolated from chronic hepatitis B patients treated with Peg-interferon plus Tenofovir therapy
    Lada, Olivier
    Zhang, Qian
    Laouenan, Cedric
    Martinot-Peignoux, Michelle
    Lapalus, Martine
    Estrabaud, Emilie
    Boyer, Nathalie
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2013, 58 : 722A - 723A
  • [24] Study on the role of natural killer cells in chronic hepatitis B patients treated with intermittent interferon therapy
    Bi, Xiaoyue
    Jiang, Tingting
    Wang, Shiyu
    Zhang, Ziyu
    Li, Xinxin
    Xie, Yao
    Li, Minghui
    JOURNAL OF HEPATOLOGY, 2024, 80 : S355 - S356
  • [25] Comparative analysis and effect of GM-CSF on neutropenia in Peg-Interferon alpha-2b and ribavirin-treated chronic hepatitis C patients
    Koliouskas, D
    Sidiropoulos, I
    Masmanidou, M
    Dokas, S
    Ziakas, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 238 - 238
  • [26] The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy
    Cao, Weihua
    Li, Minghui
    Zhang, Lu
    Lu, Yao
    Wu, Shuling
    Shen, Ge
    Chang, Min
    Liu, Ruyu
    Gao, Yuanjiao
    Hao, Hongxiao
    Hu, Leiping
    Yi, Wei
    Pan, Calvin Q.
    Xie, Yao
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [27] Impact of liver steatosis on virological response in elderly Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin
    Fabris, P
    Floreani, A
    Carlotto, A
    Baldo, V
    Bozzola, L
    Giordani, MT
    Negro, F
    Rassu, M
    Tramarin, A
    de Lalla, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (09) : 1173 - 1178
  • [28] CD56 bright NK cells and natural killer receptor expression in multiple sclerosis patients treated with interferon-beta
    Martinez-Rodriguez, J. E.
    Lopez-Botet, M.
    Munteis, E.
    Rio, J.
    Roquer, J.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S130 - S130
  • [29] SERUM HBVRNA IS AN EARLY PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH PEG-INTERFERON ALPHA-2A (40kD)
    van Boemmel, F.
    van Boemmel, A.
    Krauel, A.
    He, H.
    Wat, C.
    Pavlovic, V.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S560 - S561
  • [30] CD56 bright natural killer cell induces HBsAg clearance via cytolysis and non-cytolysis: Analysis of the OSST patient dataset
    Shi, A.
    Zhang, X.
    Xiao, F.
    Zhu, L.
    Yan, W.
    Han, M.
    Chen, T.
    Ning, Q.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S513 - S513
12345